{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:01:20Z","timestamp":1788825680654,"version":"build-2803163510"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-025-04563-8","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T19:59:16Z","timestamp":1742155156000},"page":"5081-5095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Case\u2013Control Study of Association Between Serum Levels of 19 Trace Elements with Prostate Cancer in Southwest China"],"prefix":"10.1007","volume":"203","author":[{"given":"Maoling","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Chuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"4563_CR1","doi-asserted-by":"publisher","unstructured":"Zhang J, Wang G, Huang A, Cao K, Tan W, Geng H, Lin X, Zhan F, Wu K, Zheng S, Liu C (2022) Association between serum level of multiple trace elements and esophageal squamous cell carcinoma risk: a case-control study in China. Cancers 14. https:\/\/doi.org\/10.3390\/cancers14174239","DOI":"10.3390\/cancers14174239"},{"key":"4563_CR2","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1007\/s11033-021-06694-2","volume":"48","author":"A Ay","year":"2021","unstructured":"Ay A, Gulyasar T, Alkanli N, Sipahi T, Cicin I, Kocak Z, Sut N (2021) Investigation of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in patients with colorectal cancer. Mol Biol Reports 48:6911\u20136921. https:\/\/doi.org\/10.1007\/s11033-021-06694-2","journal-title":"Mol Biol Reports"},{"key":"4563_CR3","doi-asserted-by":"publisher","unstructured":"Ge X-Y, Xie S-H, Wang H, Ye X, Chen W, Zhou H-N, Li X, Lin A-H, Cao S-M (2023) Associations between serum trace elements and the risk of nasopharyngeal carcinoma: a multi-center case-control study in Guangdong Province, southern China. Front Nutr 10. https:\/\/doi.org\/10.3389\/fnut.2023.1142861","DOI":"10.3389\/fnut.2023.1142861"},{"key":"4563_CR4","doi-asserted-by":"publisher","unstructured":"Caini S, Cozzolino F, Saieva C, Aprea MC, Cavalcabo NDB, Ermini I, Assedi M, Biagiotti D, Trane C, Facchini L, Bendinelli B, Palli D, Masala G (2023) Serum heavy metals and breast cancer risk: a case-control study nested in the Florence cohort of the EPIC (European Prospective Investigation into Cancer and nutrition) study. Sci Total Environ 861. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.160568","DOI":"10.1016\/j.scitotenv.2022.160568"},{"key":"4563_CR5","doi-asserted-by":"publisher","unstructured":"James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387:1163\u201377. https:\/\/doi.org\/10.1016\/s0140-6736(15)01037-5","DOI":"10.1016\/s0140-6736(15)01037-5"},{"key":"4563_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4563_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/cm9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ (2021) Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl) 134:783\u2013791. https:\/\/doi.org\/10.1097\/cm9.0000000000001474","journal-title":"Chin Med J (Engl)"},{"key":"4563_CR8","doi-asserted-by":"publisher","unstructured":"Sawada N, Inoue M, Iwasaki M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S (2014) Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: the Japan Public Health Center-based prospective study. Int J Cancer 134:971\u2013978.https:\/\/doi.org\/10.1002\/ijc.28423","DOI":"10.1002\/ijc.28423"},{"key":"4563_CR9","doi-asserted-by":"publisher","unstructured":"von Klot CA, Merseburger AS (2016) Comment on: \u201cLong-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years\u201d. World J Urol 34:763\u20134. https:\/\/doi.org\/10.1007\/s00345-015-1683-4","DOI":"10.1007\/s00345-015-1683-4"},{"key":"4563_CR10","doi-asserted-by":"publisher","unstructured":"Pandya C, Gupta S, Pillai P, Bhandarkar A, Khan A, Bhan A, Prajapati A, Gupta S (2013) Association of cadmium and lead with antioxidant status and incidence of benign prostatic hyperplasia in patients of Western India. Biol Trace Elem Res 152:316\u201326. https:\/\/doi.org\/10.1007\/s12011-013-9630-y","DOI":"10.1007\/s12011-013-9630-y"},{"key":"4563_CR11","doi-asserted-by":"publisher","unstructured":"Sarafanov AG, Todorov TI, Kajdacsy-Balla A, Gray MA, Macias V, Centeno JA (2008) Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J Trace Elem Med Biol 22:305\u201314. https:\/\/doi.org\/10.1016\/j.jtemb.2008.03.010","DOI":"10.1016\/j.jtemb.2008.03.010"},{"key":"4563_CR12","doi-asserted-by":"publisher","unstructured":"Malm J, Hellman J, Hogg P, Lilja H (2000) Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Prostate 45:132\u20139. https:\/\/doi.org\/10.1002\/1097-0045(20001001)45:2<132::aid-pros7>3.0.co;2-3","DOI":"10.1002\/1097-0045(20001001)45:2<132::aid-pros7>3.0.co;2-3"},{"key":"4563_CR13","doi-asserted-by":"publisher","unstructured":"Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40:200\u20137. https:\/\/doi.org\/10.1002\/(sici)1097-0045(19990801)40:3<200::aid-pros8>3.0.co;2-3","DOI":"10.1002\/(sici)1097-0045(19990801)40:3<200::aid-pros8>3.0.co;2-3"},{"key":"4563_CR14","doi-asserted-by":"publisher","unstructured":"Ishii K, Usui S, Sugimura Y, Yamamoto H, Yoshikawa K, Hirano K (2001) Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull 24:226\u201330. https:\/\/doi.org\/10.1248\/bpb.24.226","DOI":"10.1248\/bpb.24.226"},{"key":"4563_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2003.09.029","volume":"207","author":"K Ishii","year":"2004","unstructured":"Ishii K, Otsuka T, Iguchi K, Usui S, Yamamoto H, Sugimura Y, Yoshikawa K, Hayward SW, Hirano K (2004) Evidence that the prostate-specific antigen (PSA)\/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett 207:79\u201387. https:\/\/doi.org\/10.1016\/j.canlet.2003.09.029","journal-title":"Cancer Lett"},{"key":"4563_CR16","doi-asserted-by":"publisher","unstructured":"Feustel A, Wennrich R, Steiniger D, Klauss P (1982) Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 10:301\u20133. https:\/\/doi.org\/10.1007\/bf00255877","DOI":"10.1007\/bf00255877"},{"key":"4563_CR17","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/1097-0142(19890401)63:7<1388::aid-cncr2820630725>3.0.co;2-m","volume":"63","author":"JO Ogunlewe","year":"1989","unstructured":"Ogunlewe JO, Osegbe DN (1989) Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 63:1388\u201392. https:\/\/doi.org\/10.1002\/1097-0142(19890401)63:7<1388::aid-cncr2820630725>3.0.co;2-m","journal-title":"Cancer"},{"key":"4563_CR18","doi-asserted-by":"publisher","unstructured":"Zaichick V, Sviridova TV, Zaichick SV (1997) Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29:565\u201374. https:\/\/doi.org\/10.1007\/bf02552202","DOI":"10.1007\/bf02552202"},{"key":"4563_CR19","doi-asserted-by":"publisher","unstructured":"Bry\u015b M, Nawrocka AD, Mieko\u015b E, Zydek C, Foksi\u0144ski M, Barecki A, Krajewska WM (1997) Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 59:145\u201352. https:\/\/doi.org\/10.1007\/bf02783239","DOI":"10.1007\/bf02783239"},{"key":"4563_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1476-4598-4-32","volume":"4","author":"RB Franklin","year":"2005","unstructured":"Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC (2005) hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 4:32. https:\/\/doi.org\/10.1186\/1476-4598-4-32","journal-title":"Mol Cancer"},{"key":"4563_CR21","doi-asserted-by":"publisher","first-page":"25778","DOI":"10.1038\/srep25778","volume":"6","author":"J Zhao","year":"2016","unstructured":"Zhao J, Wu Q, Hu X, Dong X, Wang L, Liu Q, Long Z, Li L (2016) Comparative study of serum zinc concentrations in benign and malignant prostate disease: a systematic review and meta-analysis. Sci Rep 6:25778. https:\/\/doi.org\/10.1038\/srep25778","journal-title":"Sci Rep"},{"key":"4563_CR22","doi-asserted-by":"publisher","unstructured":"Etminan M, FitzGerald JM, Gleave M, Chambers K (2005) Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16:1125\u201331. https:\/\/doi.org\/10.1007\/s10552-005-0334-2","DOI":"10.1007\/s10552-005-0334-2"},{"key":"4563_CR23","first-page":"883","volume":"9","author":"AM Nomura","year":"2000","unstructured":"Nomura AM, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 9:883\u2013887","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4563_CR24","first-page":"1401","volume":"24","author":"ML Smith","year":"2004","unstructured":"Smith ML, Lancia JK, Mercer TI, Ip C (2004) Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 24:1401\u20131408","journal-title":"Anticancer Res"},{"key":"4563_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/taap.1999.8907","volume":"164","author":"WE Achanzar","year":"2000","unstructured":"Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP (2000) Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol 164:291\u2013300. https:\/\/doi.org\/10.1006\/taap.1999.8907","journal-title":"Toxicol Appl Pharmacol"},{"key":"4563_CR26","doi-asserted-by":"publisher","unstructured":"Neslund-Dudas C, Kandegedara A, Kryvenko ON, Gupta N, Rogers C, Rybicki BA, Dou QP, Mitra B (2014) Prostate tissue metal levels and prostate cancer recurrence in smokers. Biol Trace Elem Res 157:107\u201312. https:\/\/doi.org\/10.1007\/s12011-013-9874-6","DOI":"10.1007\/s12011-013-9874-6"},{"key":"4563_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2016.10.020","volume":"457","author":"V Vella","year":"2017","unstructured":"Vella V, Malaguarnera R, Lappano R, Maggiolini M, Belfiore A (2017) Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer. Mol Cell Endocrino 457:57\u201372. https:\/\/doi.org\/10.1016\/j.mce.2016.10.020","journal-title":"Mol Cell Endocrino"},{"key":"4563_CR28","doi-asserted-by":"publisher","unstructured":"Deegan BJ, Bona AM, Bhat V, Mikles DC, McDonald CB, Seldeen KL, Farooq A (2011) Structural and thermodynamic consequences of the replacement of zinc with environmental metals on estrogen receptor \u03b1-DNA interactions. J Mol Recognit 24:1007\u201317. https:\/\/doi.org\/10.1002\/jmr.1148","DOI":"10.1002\/jmr.1148"},{"key":"4563_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/toxsci\/kfm013","volume":"98","author":"JC Davey","year":"2007","unstructured":"Davey JC, Bodwell JE, Gosse JA, Hamilton JW (2007) Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98:75\u201386. https:\/\/doi.org\/10.1093\/toxsci\/kfm013","journal-title":"Toxicol Sci"},{"key":"4563_CR30","doi-asserted-by":"publisher","first-page":"113724","DOI":"10.1016\/j.ecoenv.2022.113724","volume":"241","author":"Y Qie","year":"2022","unstructured":"Qie Y, Zhou D, Wu Z, Liu S, Shen C, Hu H, Zhang C, Xu Y (2022) Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway. Ecotoxicol Environ Saf 241:113724. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113724","journal-title":"Ecotoxicol Environ Saf"},{"key":"4563_CR31","doi-asserted-by":"publisher","unstructured":"Alegre-Mart\u00ednez A, Mart\u00ednez-Mart\u00ednez MI, Rubio-Briones J, Cauli O (2022) Plasma nickel levels correlate with low muscular strength and renal function parameters in patients with prostate cancer. Diseases 10. https:\/\/doi.org\/10.3390\/diseases10030039","DOI":"10.3390\/diseases10030039"},{"key":"4563_CR32","doi-asserted-by":"publisher","first-page":"116728","DOI":"10.1016\/j.taap.2023.116728","volume":"479","author":"B Tyagi","year":"2023","unstructured":"Tyagi B, Chandrasekaran B, Tyagi A, Shukla V, Saran U, Tyagi N, Talluri S, Juneau AD, Fu H, Ankem MK, Damodaran C (2023) Exposure of environmental trace elements in prostate cancer patients: a multiple metal analysis. Toxicol Appl Pharmacol 479:116728. https:\/\/doi.org\/10.1016\/j.taap.2023.116728","journal-title":"Toxicol Appl Pharmacol"},{"key":"4563_CR33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.envint.2018.10.034","volume":"121","author":"WH Chang","year":"2018","unstructured":"Chang WH, Lee CC, Yen YH, Chen HL (2018) Oxidative damage in patients with benign prostatic hyperplasia and prostate cancer co-exposed to phthalates and to trace elements. Environ Int 121:1179\u20131184. https:\/\/doi.org\/10.1016\/j.envint.2018.10.034","journal-title":"Environ Int"},{"key":"4563_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12011-011-9162-2","volume":"145","author":"S Guzel","year":"2012","unstructured":"Guzel S, Kiziler L, Aydemir B, Alici B, Ataus S, Aksu A, Durak H (2012) Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma. Biol Trace Elem Res 145:23\u201332. https:\/\/doi.org\/10.1007\/s12011-011-9162-2","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12011-015-0576-0","volume":"172","author":"L Zhang","year":"2016","unstructured":"Zhang L, Zhu Y, Hao R, Shao M, Luo Y (2016) Cadmium levels in tissue and plasma as a risk factor for prostate carcinoma: a meta-analysis. Biol Trace Elem Res 172:86\u201392. https:\/\/doi.org\/10.1007\/s12011-015-0576-0","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000499261","volume":"14","author":"SAK Saleh","year":"2020","unstructured":"Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM (2020) Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr Urol 14:44\u201349. https:\/\/doi.org\/10.1159\/000499261","journal-title":"Curr Urol"},{"key":"4563_CR37","doi-asserted-by":"publisher","unstructured":"Sarafanov AG, Todorov TI, Centeno JA, Macias V, Gao W, Liang WM, Beam C, Gray MA, Kajdacsy-Balla AA (2011) Prostate cancer outcome and tissue levels of metal ions. Prostate 71:1231\u20138. https:\/\/doi.org\/10.1002\/pros.21339","DOI":"10.1002\/pros.21339"},{"key":"4563_CR38","doi-asserted-by":"publisher","first-page":"e0250744","DOI":"10.1371\/journal.pone.0250744","volume":"16","author":"H Wu","year":"2021","unstructured":"Wu H, Wang M, Raman JD, McDonald AC (2021) Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States. PLoS One 16:e0250744. https:\/\/doi.org\/10.1371\/journal.pone.0250744","journal-title":"PLoS One"},{"key":"4563_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajur.2017.11.009","volume":"6","author":"V Zaichick","year":"2019","unstructured":"Zaichick V, Zaichick S (2019) Comparison of 66 chemical element contents in normal and benign hyperplastic prostate. Asian J Urol 6:275\u2013289. https:\/\/doi.org\/10.1016\/j.ajur.2017.11.009","journal-title":"Asian J Urol"},{"key":"4563_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12011-014-0123-4","volume":"162","author":"MA Qayyum","year":"2014","unstructured":"Qayyum MA, Shah MH (2014) Comparative study of trace elements in blood, scalp hair and nails of prostate cancer patients in relation to healthy donors. Biol Trace Elem Res 162:46\u201357. https:\/\/doi.org\/10.1007\/s12011-014-0123-4","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR41","doi-asserted-by":"publisher","unstructured":"Singh BP, Dwivedi S, Dhakad U, Murthy RC, Choubey VK, Goel A, Sankhwar SN (2016) Status and interrelationship of zinc, copper, iron, calcium and selenium in prostate cancer. Indian J Clin Biochem 31:50\u20136. https:\/\/doi.org\/10.1007\/s12291-015-0497-x","DOI":"10.1007\/s12291-015-0497-x"},{"key":"4563_CR42","doi-asserted-by":"publisher","unstructured":"Pizent A, An\u0111elkovi\u0107 M, Tariba Lovakovi\u0107 B, \u017divkovi\u0107 Semren T, Buha Djordjevic A, Gamulin M, Bonderovi\u0107 V, A\u0107imovi\u0107 M, Bulat Z (2022) Environmental exposure to metals, parameters of oxidative stress in blood and prostate cancer: results from two cohorts. Antioxidants (Basel) 11. https:\/\/doi.org\/10.3390\/antiox11102044","DOI":"10.3390\/antiox11102044"},{"key":"4563_CR43","doi-asserted-by":"publisher","first-page":"355.e9","DOI":"10.1016\/j.urolonc.2023.04.022","volume":"41","author":"V Singh","year":"2023","unstructured":"Singh V, Madeshiya AK, Ansari NG, Singh MK, Abhishek A (2023) CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: an explorative case-control study. Urol Oncol 41:355.e9-355.e17. https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.022","journal-title":"Urol Oncol"},{"key":"4563_CR44","doi-asserted-by":"publisher","unstructured":"Kaba M, Pirincci N, Yuksel MB, Gecit I, Gunes M, Ozveren H, Eren H, Demir H (2014) Serum levels of trace elements in patients with prostate cancer. Asian Pac J Cancer Prev 15:2625\u20139. https:\/\/doi.org\/10.7314\/apjcp.2014.15.6.2625","DOI":"10.7314\/apjcp.2014.15.6.2625"},{"key":"4563_CR45","doi-asserted-by":"publisher","first-page":"105109","DOI":"10.1016\/j.envint.2019.105109","volume":"132","author":"JT Lim","year":"2019","unstructured":"Lim JT, Tan YQ, Valeri L, Lee J, Geok PP, Chia SE, Ong CN, Seow WJ (2019) Association between serum heavy metals and prostate cancer risk - a multiple metal analysis. Environ Int 132:105109. https:\/\/doi.org\/10.1016\/j.envint.2019.105109","journal-title":"Environ Int"},{"key":"4563_CR46","doi-asserted-by":"publisher","first-page":"126819","DOI":"10.1016\/j.jtemb.2021.126819","volume":"68","author":"Y Gong","year":"2021","unstructured":"Gong Y, Lin Z, Gan X, Yang G, Li M, Tan Y, Zheng S, Wang X, Luo Z, Jiao Y, Teng R, Yang X (2021) Diagnostic potential of trace metals concentration in expressed prostatic secretion and serum of patients with category IV prostatitis. J Trace Elem Med Biol 68:126819. https:\/\/doi.org\/10.1016\/j.jtemb.2021.126819","journal-title":"J Trace Elem Med Biol"},{"key":"4563_CR47","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.redox.2021.101900","volume":"42","author":"K Lossow","year":"2021","unstructured":"Lossow K, Schwarz M, Kipp AP (2021) Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol 42:101900. https:\/\/doi.org\/10.1016\/j.redox.2021.101900","journal-title":"Redox Biol"},{"key":"4563_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/0973-029x.131902","volume":"18","author":"SS Hosthor","year":"2014","unstructured":"Hosthor SS, Mahesh P, Priya SA, Sharada P, Jyotsna M, Chitra S (2014) Quantitative analysis of serum levels of trace elements in patients with oral submucous fibrosis and oral squamous cell carcinoma: a randomized cross-sectional study. Journal of oral and maxillofacial pathology\u202f: JOMFP 18:46\u201351. https:\/\/doi.org\/10.4103\/0973-029x.131902","journal-title":"Journal of oral and maxillofacial pathology : JOMFP"},{"key":"4563_CR49","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.2147\/cmar.S250592","volume":"12","author":"Y Lin","year":"2020","unstructured":"Lin Y, Wu C, Yan W, Guo S, Liu B (2020) Five serum trace elements associated with risk of cardia and noncardia gastric cancer in a matched case-control study. Cancer Management and Research 12:4441\u20134451. https:\/\/doi.org\/10.2147\/cmar.S250592","journal-title":"Cancer Management and Research"},{"key":"4563_CR50","doi-asserted-by":"publisher","unstructured":"Lubinski J, Lener MR, Marciniak W, Pietrzak S, Derkacz R, Cybulski C, Gronwald J, Debniak T, Jakubowska A, Huzarski T, Matuszczak M, Pullella K, Sun P, Narod SA (2023) Serum essential elements and survival after cancer diagnosis. Nutrients 15. https:\/\/doi.org\/10.3390\/nu15112611","DOI":"10.3390\/nu15112611"},{"key":"4563_CR51","doi-asserted-by":"publisher","unstructured":"Alegre-Martinez A, Martinez-Martinez MI, Rubio-Briones J, Cauli O (2022) Plasma nickel levels correlate with low muscular strength and renal function parameters in patients with prostate cancer. Diseases 10. https:\/\/doi.org\/10.3390\/diseases10030039","DOI":"10.3390\/diseases10030039"},{"key":"4563_CR52","doi-asserted-by":"publisher","unstructured":"Gong Y, Lin Z, Gan X, Yang G, Li M, Tan Y, Zheng S, Wang X, Luo Z, Jiao Y, Teng R, Yang X (2021) Diagnostic potential of trace metals concentration in expressed prostatic secretion and serum of patients with category IV prostatitis. J Trace Elem Med Biol 68. https:\/\/doi.org\/10.1016\/j.jtemb.2021.126819","DOI":"10.1016\/j.jtemb.2021.126819"},{"key":"4563_CR53","doi-asserted-by":"publisher","unstructured":"Lim JT, Tan YQ, Valeri L, Lee J, Geok PP, Chia SE, Ong CN, Seow WJ (2019) Association between serum heavy metals and prostate cancer risk - a multiple metal analysis. EnvironInt 132. https:\/\/doi.org\/10.1016\/j.envint.2019.105109","DOI":"10.1016\/j.envint.2019.105109"},{"key":"4563_CR54","doi-asserted-by":"publisher","unstructured":"Pizent A, Andelkovic M, Lovakovic BT, Semren TZ, Djordjevic AB, Gamulin M, Bonderovic V, Acimovic M, Bulat Z (2022) Environmental exposure to metals, parameters of oxidative stress in blood and prostate cancer: results from two cohorts. Antioxidants 11. https:\/\/doi.org\/10.3390\/antiox11102044","DOI":"10.3390\/antiox11102044"},{"key":"4563_CR55","doi-asserted-by":"publisher","unstructured":"Singh V, Madeshiya AK, Ansari NG, Singh MK, Abhishek A (2023) CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: an explorative case-control study. Urol Oncology-Seminars Original Invest 41:355e9\u2013355e17. https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.022","DOI":"10.1016\/j.urolonc.2023.04.022"},{"key":"4563_CR56","doi-asserted-by":"publisher","unstructured":"Tyagi B, Chandrasekaran B, Tyagi A, Shukla V, Saran U, Tyagi N, Talluri S, Juneau AD, Fu H, Ankem MK, Damodaran C (2023) Exposure of environmental trace elements in prostate cancer patients: a multiple metal analysis. Toxicol Appl Pharmacol 479. https:\/\/doi.org\/10.1016\/j.taap.2023.116728","DOI":"10.1016\/j.taap.2023.116728"},{"key":"4563_CR57","doi-asserted-by":"publisher","unstructured":"Wu H, Wang M, Raman JD, McDonald AC (2021) Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States. Plos One 16. https:\/\/doi.org\/10.1371\/journal.pone.0250744","DOI":"10.1371\/journal.pone.0250744"},{"key":"4563_CR58","doi-asserted-by":"publisher","unstructured":"Darag\u00f3 A, Sapota A, Matych J, Nasiadek M, Skrzypi\u0144ska-Gawrysiak M, Kilanowicz A (2011) The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer. Clin Chem Lab Med 49:1699\u2013705. https:\/\/doi.org\/10.1515\/cclm.2011.651","DOI":"10.1515\/cclm.2011.651"},{"key":"4563_CR59","unstructured":"Agency EM (2022) ICH guideline M10 on bioanalytical method validation and study sample analysis. Retrieved from www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. Accessed 5 Feb 2025"},{"key":"4563_CR60","doi-asserted-by":"publisher","unstructured":"He SQ, Nie MQ, Zhang J, Feng XF, Zhao XY, Li NN, Zhang TA, Wang X, Zeng HY, Zou XL (2023) Study on pre-treatment methods for the determination of 21 elements in serum. J Prev Med Inform 1\u20137. https:\/\/doi.org\/10.19971\/j.cnki.1006-4028.230481","DOI":"10.19971\/j.cnki.1006-4028.230481"},{"issue":"4","key":"4563_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.soncn.2011.07.002","volume":"27","author":"MW Dunn","year":"2011","unstructured":"Dunn MW, Kazer MW (2011) Prostate cancer overview. Semin Oncol Nurs 27(4):241\u2013250. https:\/\/doi.org\/10.1016\/j.soncn.2011.07.002","journal-title":"Semin Oncol Nurs"},{"key":"4563_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ncpuro1290","volume":"6","author":"AR Patel","year":"2009","unstructured":"Patel AR, Klein EA (2009) Risk factors for prostate cancer. Nat Clin Pract Urol 6:87\u201395. https:\/\/doi.org\/10.1038\/ncpuro1290","journal-title":"Nat Clin Pract Urol"},{"key":"4563_CR63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/s1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, Graham J, Kirkbride P, Logue J, Malik Z, Money-Kyrle J, O\u2019Sullivan JM, Panades M, Parker C, Patterson H, Scrase C, Staffurth J, Stockdale A, Tremlett J, Bidmead M, Mayles H, Naismith O, South C, Gao A, Cruickshank C, Hassan S, Pugh J, Griffin C, Hall E (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol 17:1047\u20131060. https:\/\/doi.org\/10.1016\/s1470-2045(16)30102-4","journal-title":"Lancet Oncol"},{"key":"4563_CR64","doi-asserted-by":"publisher","unstructured":"Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O'Shea N, Scher H, Holland JC, Slovin S, Curley-Smart T, Reynolds T, Breitbart W (2006) Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 47:340\u20137. https:\/\/doi.org\/10.1176\/appi.psy.47.4.340","DOI":"10.1176\/appi.psy.47.4.340"},{"key":"4563_CR65","doi-asserted-by":"publisher","unstructured":"Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH, Halabi S, Kantoff PW, Armstrong AJ (2016) Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol 34:1402\u201318. https:\/\/doi.org\/10.1200\/jco.2015.64.2702","DOI":"10.1200\/jco.2015.64.2702"},{"key":"4563_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5152\/eurasianjmed.2021.20407","volume":"53","author":"O Araz","year":"2021","unstructured":"Araz O, Araz A (2021) Are trace element concentrations in lung cancer tissue associated with metastasis? Eurasian J Med 53:227\u2013230. https:\/\/doi.org\/10.5152\/eurasianjmed.2021.20407","journal-title":"Eurasian J Med"},{"key":"4563_CR67","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1007\/s12011-021-03089-z","volume":"200","author":"S Iqbal","year":"2022","unstructured":"Iqbal S, Ali I (2022) Dietary trace element intake and risk of breast cancer: a mini review. Biol Trace Elem Res 200:4936\u20134948. https:\/\/doi.org\/10.1007\/s12011-021-03089-z","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR68","doi-asserted-by":"publisher","unstructured":"Ma X, Yang Y, Li HL, Zheng W, Gao J, Zhang W, Yang G, Shu XO, Xiang YB (2017) Dietary trace element intake and liver cancer risk: results from two population-based cohorts in China. Int J Cancer 140:1050\u20131059. https:\/\/doi.org\/10.1002\/ijc.30522","DOI":"10.1002\/ijc.30522"},{"key":"4563_CR69","doi-asserted-by":"publisher","unstructured":"Franklin RB, Costello LC (2007) Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 463:211\u20137. https:\/\/doi.org\/10.1016\/j.abb.2007.02.033","DOI":"10.1016\/j.abb.2007.02.033"},{"key":"4563_CR70","doi-asserted-by":"publisher","unstructured":"Platz EA, Helzlsouer KJ (2001) Selenium, zinc, and prostate cancer. Epidemiol Rev 23:93\u2013101. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a000801","DOI":"10.1093\/oxfordjournals.epirev.a000801"},{"key":"4563_CR71","doi-asserted-by":"publisher","unstructured":"Bonaventura P, Benedetti G, Albar\u00e8de F, Miossec P (2015) Zinc and its role in immunity and inflammation. Autoimmun Rev 14:277\u201385. https:\/\/doi.org\/10.1016\/j.autrev.2014.11.008","DOI":"10.1016\/j.autrev.2014.11.008"},{"key":"4563_CR72","doi-asserted-by":"publisher","unstructured":"Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ (2012) Heavy metal toxicity and the environment. Exp Suppl 101:133\u201364. https:\/\/doi.org\/10.1007\/978-3-7643-8340-4_6","DOI":"10.1007\/978-3-7643-8340-4_6"},{"key":"4563_CR73","doi-asserted-by":"publisher","unstructured":"Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, Ramazzotti V, Tavani A, Dal Maso L, La Vecchia C (2007) Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 52:1052\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2007.01.094","DOI":"10.1016\/j.eururo.2007.01.094"},{"key":"4563_CR74","doi-asserted-by":"publisher","unstructured":"Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004\u20137. https:\/\/doi.org\/10.1093\/jnci\/95.13.1004","DOI":"10.1093\/jnci\/95.13.1004"},{"key":"4563_CR75","doi-asserted-by":"publisher","unstructured":"Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L (2009) Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control 20:691\u20138. https:\/\/doi.org\/10.1007\/s10552-008-9282-y","DOI":"10.1007\/s10552-008-9282-y"},{"key":"4563_CR76","doi-asserted-by":"publisher","unstructured":"Andersson SO, Wolk A, Bergstr\u00f6m R, Giovannucci E, Lindgren C, Baron J, Adami HO (1996) Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 68:716\u201322. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19961211)68:6<716::Aid-ijc4>3.0.Co;2-6","DOI":"10.1002\/(sici)1097-0215(19961211)68:6<716::Aid-ijc4>3.0.Co;2-6"},{"key":"4563_CR77","doi-asserted-by":"publisher","unstructured":"Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN (2013) Serum zinc and prostate cancer risk in a nested case-control study: the multiethnic cohort. Prostate 73:261\u20136. https:\/\/doi.org\/10.1002\/pros.22565","DOI":"10.1002\/pros.22565"},{"key":"4563_CR78","doi-asserted-by":"publisher","unstructured":"Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288\u201396. https:\/\/doi.org\/10.1002\/pros.10115","DOI":"10.1002\/pros.10115"},{"key":"4563_CR79","doi-asserted-by":"publisher","unstructured":"Ekmekcioglu C (2001) The role of trace elements for the health of elderly individuals. Nahrung 45:309\u201316. https:\/\/doi.org\/10.1002\/1521-3803(20011001)45:5<309::Aid-food309>3.0.Co;2-0","DOI":"10.1002\/1521-3803(20011001)45:5<309::Aid-food309>3.0.Co;2-0"},{"key":"4563_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0094-0143(02)00018-6","volume":"29","author":"MA Nelson","year":"2002","unstructured":"Nelson MA, Reid M, Duffield-Lillico AJ, Marshall JR (2002) Prostate cancer and selenium. Urol Clin North Am 29:67\u201370. https:\/\/doi.org\/10.1016\/s0094-0143(02)00018-6","journal-title":"Urol Clin North Am"},{"key":"4563_CR81","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1007\/s12011-022-03467-1","volume":"201","author":"JP D\u00e1vila-Vega","year":"2023","unstructured":"D\u00e1vila-Vega JP, Gastelum-Hern\u00e1ndez AC, Serrano-Sandoval SN, Serna-Sald\u00edvar SO, Guiti\u00e9rrez-Uribe JA, Mil\u00e1n-Carrillo J, Mart\u00ednez-Cuesta MC, Guardado-F\u00e9lix D (2023) Metabolism and anticancer mechanisms of selocompounds: comprehensive review. Biol Trace Elem Res 201:3626\u20133644. https:\/\/doi.org\/10.1007\/s12011-022-03467-1","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR82","doi-asserted-by":"publisher","unstructured":"Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Jr., Baker LH, Coltman CA, Jr. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama 301:39\u201351. https:\/\/doi.org\/10.1001\/jama.2008.864","DOI":"10.1001\/jama.2008.864"},{"key":"4563_CR83","doi-asserted-by":"publisher","first-page":"djt456","DOI":"10.1093\/jnci\/djt456","volume":"106","author":"AR Kristal","year":"2014","unstructured":"Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA (2014) Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 106:djt456. https:\/\/doi.org\/10.1093\/jnci\/djt456","journal-title":"J Natl Cancer Inst"},{"key":"4563_CR84","doi-asserted-by":"publisher","first-page":"663","DOI":"10.5604\/01.3001.0010.3846","volume":"71","author":"M Og\u00f3rek","year":"2017","unstructured":"Og\u00f3rek M, G\u0105sior \u0141, Pierzcha\u0142a O, Daszkiewicz R, Lenartowicz M (2017) Role of copper in the process of spermatogenesis. Postepy Hig Med Dosw (Online) 71:663\u2013683. https:\/\/doi.org\/10.5604\/01.3001.0010.3846","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"4563_CR85","doi-asserted-by":"publisher","first-page":"382","DOI":"10.23736\/s1824-4785.20.03277-x","volume":"64","author":"A Piccardo","year":"2020","unstructured":"Piccardo A, Ugolini M, Righi S, Bottoni G, Cistaro A, Paparo F, Giovanella L, Evangelista L (2020) Copper, PET\/CT and prostate cancer: a systematic review of the literature. Q J Nucl Med Mol Imaging 64:382\u2013392. https:\/\/doi.org\/10.23736\/s1824-4785.20.03277-x","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"4563_CR86","doi-asserted-by":"publisher","unstructured":"Majumder S, Chatterjee S, Pal S, Biswas J, Efferth T, Choudhuri SK (2009) The role of copper in drug-resistant murine and human tumors. Biometals 22:377\u201384. https:\/\/doi.org\/10.1007\/s10534-008-9174-3","DOI":"10.1007\/s10534-008-9174-3"},{"key":"4563_CR87","doi-asserted-by":"publisher","first-page":"952s","DOI":"10.1093\/ajcn\/67.5.952S","volume":"67","author":"R Uauy","year":"1998","unstructured":"Uauy R, Olivares M, Gonzalez M (1998) Essentiality of copper in humans. Am J Clin Nutr 67:952s\u2013959s. https:\/\/doi.org\/10.1093\/ajcn\/67.5.952S","journal-title":"Am J Clin Nutr"},{"key":"4563_CR88","doi-asserted-by":"publisher","unstructured":"Parr-Sturgess CA, Tinker CL, Hart CA, Brown MD, Clarke NW, Parkin ET (2012) Copper modulates zinc metalloproteinase-dependent ectodomain shedding of key signaling and adhesion proteins and promotes the invasion of prostate cancer epithelial cells. Mol Cancer Res 10:1282\u201393. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-12-0312","DOI":"10.1158\/1541-7786.Mcr-12-0312"},{"key":"4563_CR89","doi-asserted-by":"publisher","unstructured":"Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Shumin Z, Lili D (2003) Serum and tissue levels of six trace elements and copper\/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res 94:113\u201322. https:\/\/doi.org\/10.1385\/bter:94:2:113","DOI":"10.1385\/bter:94:2:113"},{"key":"4563_CR90","doi-asserted-by":"publisher","unstructured":"Darbre PD (2005) Aluminium, antiperspirants and breast cancer. J Inorg Biochem 99:1912\u20139. https:\/\/doi.org\/10.1016\/j.jinorgbio.2005.06.001","DOI":"10.1016\/j.jinorgbio.2005.06.001"},{"key":"4563_CR91","doi-asserted-by":"publisher","first-page":"111402","DOI":"10.1016\/j.fct.2020.111402","volume":"141","author":"CH Jeong","year":"2020","unstructured":"Jeong CH, Kwon HC, Cheng WN, Kim DH, Choi Y, Han SG (2020) Aluminum exposure promotes the metastatic proclivity of human colorectal cancer cells through matrix metalloproteinases and the TGF-\u03b2\/Smad signaling pathway. Food Chem Toxicol 141:111402. https:\/\/doi.org\/10.1016\/j.fct.2020.111402","journal-title":"Food Chem Toxicol"},{"key":"4563_CR92","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ajim.23150","volume":"63","author":"ES McClure","year":"2020","unstructured":"McClure ES, Vasudevan P, DeBono N, Robinson WR, Marshall SW, Richardson D (2020) Cancer and noncancer mortality among aluminum smelting workers in Badin, North Carolina. Am J Ind Med 63:755\u2013765. https:\/\/doi.org\/10.1002\/ajim.23150","journal-title":"Am J Ind Med"},{"key":"4563_CR93","doi-asserted-by":"publisher","unstructured":"Spinelli JJ, Band PR, Svirchev LM, Gallagher RP (1991) Mortality and cancer incidence in aluminum reduction plant workers. J Occup Med 33:1150\u20135.https:\/\/doi.org\/10.1097\/00043764-199111000-00011","DOI":"10.1097\/00043764-199111000-00011"},{"key":"4563_CR94","doi-asserted-by":"publisher","unstructured":"Andr\u00e1si E, P\u00e1li N, Moln\u00e1r Z, K\u00f6sel S (2005) Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J Alzheimers Dis 7:273\u201384. https:\/\/doi.org\/10.3233\/jad-2005-7402","DOI":"10.3233\/jad-2005-7402"},{"issue":"2","key":"4563_CR95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-7992(83)90129-x","volume":"119","author":"JR McLean","year":"1983","unstructured":"McLean JR, Blakey DH, Douglas GR, Kaplan JG (1983) The effect of stannous and stannic (tin) chloride on DNA in Chinese hamster ovary cells. Mutat Res Lett 119(2):195\u2013201. https:\/\/doi.org\/10.1016\/0165-7992(83)90129-x","journal-title":"Mutat Res Lett"},{"key":"4563_CR96","doi-asserted-by":"publisher","unstructured":"Nagano K, Nishizawa T, Umeda Y, Kasai T, Noguchi T, Gotoh K, Ikawa N, Eitaki Y, Kawasumi Y, Yamauchi T, Arito H, Fukushima S (2011) Inhalation carcinogenicity and chronic toxicity of indium-tin oxide in rats and mice. J Occup Health 53:175\u201387. https:\/\/doi.org\/10.1539\/joh.10-0057-oa","DOI":"10.1539\/joh.10-0057-oa"},{"key":"4563_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","volume":"160","author":"M Valko","year":"2006","unstructured":"Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1\u201340. https:\/\/doi.org\/10.1016\/j.cbi.2005.12.009","journal-title":"Chem Biol Interact"},{"key":"4563_CR98","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.envres.2016.04.030","volume":"148","author":"CM Bulka","year":"2016","unstructured":"Bulka CM, Jones RM, Turyk ME, Stayner LT, Argos M (2016) Arsenic in drinking water and prostate cancer in Illinois counties: an ecologic study. Environ Res 148:450\u2013456. https:\/\/doi.org\/10.1016\/j.envres.2016.04.030","journal-title":"Environ Res"},{"key":"4563_CR99","doi-asserted-by":"publisher","unstructured":"Choi JY, Neuhouser ML, Barnett MJ, Hong CC, Kristal AR, Thornquist MD, King IB, Goodman GE, Ambrosone CB (2008) Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 29:964\u2013970. https:\/\/doi.org\/10.1093\/carcin\/bgn056","DOI":"10.1093\/carcin\/bgn056"},{"key":"4563_CR100","doi-asserted-by":"publisher","unstructured":"Goulart M, Bator\u00e9u MC, Rodrigues AS, Laires A, Rueff J (2005) Lipoperoxidation products and thiol antioxidants in chromium exposed workers. Mutagenesis 20:311\u20135. https:\/\/doi.org\/10.1093\/mutage\/gei043","DOI":"10.1093\/mutage\/gei043"},{"key":"4563_CR101","doi-asserted-by":"publisher","unstructured":"Karimi G, Shahar S, Homayouni N, Rajikan R, Abu Bakar NF, Othman MS (2012) Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev 13:4249\u20134253. https:\/\/doi.org\/10.7314\/apjcp.2012.13.9.4249","DOI":"10.7314\/apjcp.2012.13.9.4249"},{"key":"4563_CR102","doi-asserted-by":"publisher","first-page":"126992","DOI":"10.1016\/j.jtemb.2022.126992","volume":"72","author":"Y Yang","year":"2022","unstructured":"Yang Y, McDonald AC, Wang X, Pan Y, Wang M (2022) Arsenic exposures and prostate cancer risk: a multilevel meta-analysis. J Trace Elem Med Biol 72:126992. https:\/\/doi.org\/10.1016\/j.jtemb.2022.126992","journal-title":"J Trace Elem Med Biol"},{"key":"4563_CR103","doi-asserted-by":"publisher","first-page":"117458","DOI":"10.1016\/j.cca.2023.117458","volume":"547","author":"F Marongiu","year":"2023","unstructured":"Marongiu F, Marongiu S, Ruberto MF, Faa G, Barcellona D (2023) Trace metals and the hemostatic system. Clin Chim Acta 547:117458. https:\/\/doi.org\/10.1016\/j.cca.2023.117458","journal-title":"Clin Chim Acta"},{"key":"4563_CR104","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s12011-021-02719-w","volume":"200","author":"M Ozturk","year":"2022","unstructured":"Ozturk M, Metin M, Altay V, Bhat RA, Ejaz M, Gul A, Unal BT, Hasanuzzaman M, Nibir L, Nahar K, Bukhari A, Dervash MA, Kawano T (2022) Arsenic and human health: genotoxicity, epigenomic effects, and cancer signaling. Biol Trace Elem Res 200:988\u20131001. https:\/\/doi.org\/10.1007\/s12011-021-02719-w","journal-title":"Biol Trace Elem Res"},{"key":"4563_CR105","doi-asserted-by":"publisher","unstructured":"Renu K, Chakraborty R, Myakala H, Koti R, Famurewa AC, Madhyastha H, Vellingiri B, George A, Valsala Gopalakrishnan A (2021) Molecular mechanism of heavy metals (lead, chromium, arsenic, mercury, nickel and cadmium) - induced hepatotoxicity - a review. Chemosphere 271:129735. https:\/\/doi.org\/10.1016\/j.chemosphere.2021.129735","DOI":"10.1016\/j.chemosphere.2021.129735"},{"key":"4563_CR106","doi-asserted-by":"publisher","unstructured":"Teschke R (2022) Aluminum, arsenic, beryllium, cadmium, chromium, cobalt, copper, iron, lead, mercury, molybdenum, nickel, platinum, thallium, titanium, vanadium, and zinc: molecular aspects in experimental liver injury. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms232012213","DOI":"10.3390\/ijms232012213"},{"key":"4563_CR107","doi-asserted-by":"publisher","unstructured":"Doolan G, Benke G, Giles G (2014) An update on occupation and prostate cancer. Asian Pac J Cancer Prev 15:501\u201316. https:\/\/doi.org\/10.7314\/apjcp.2014.15.2.501","DOI":"10.7314\/apjcp.2014.15.2.501"},{"key":"4563_CR108","doi-asserted-by":"publisher","unstructured":"Fritschi L, Glass DC, Tabrizi JS, Leavy JE, Ambrosini GL (2007) Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia. Occup Environ Med 64:60\u20135. https:\/\/doi.org\/10.1136\/oem.2006.027706","DOI":"10.1136\/oem.2006.027706"},{"key":"4563_CR109","doi-asserted-by":"publisher","unstructured":"Kuvibidila S, Gauthier T, Warrier RP, Rayford W (2004) Increased levels of serum transferrin receptor and serum transferrin receptor\/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med 144:176\u201382. https:\/\/doi.org\/10.1016\/j.lab.2004.03.017","DOI":"10.1016\/j.lab.2004.03.017"},{"key":"4563_CR110","doi-asserted-by":"publisher","unstructured":"Zaichick S, Zaichick V (2012) Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis. Appl Radiat Isot 70:81\u20137. https:\/\/doi.org\/10.1016\/j.apradiso.2011.08.021","DOI":"10.1016\/j.apradiso.2011.08.021"},{"key":"4563_CR111","doi-asserted-by":"publisher","unstructured":"Sch\u00f6pfer J, Drasch G, Schrauzer GN (2010) Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers. Biol Trace Elem Res 134:180\u20137. https:\/\/doi.org\/10.1007\/s12011-010-8636-y","DOI":"10.1007\/s12011-010-8636-y"},{"key":"4563_CR112","doi-asserted-by":"publisher","unstructured":"Umbehr MH, Gurel B, Murtola TJ, Sutcliffe S, Peskoe SB, Tangen CM, Goodman PJ, Thompson IM, Lippman SM, Lucia MS, Parnes HL, Drake CG, Nelson WG, De Marzo AM, Platz EA (2015) Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4\u2009ng\u2009ml(-1), normal DRE and negative for prostate cancer. Prostate Cancer Prostatic Dis 18:264\u2013269. https:\/\/doi.org\/10.1038\/pcan.2015.19","DOI":"10.1038\/pcan.2015.19"},{"key":"4563_CR113","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4103\/jcrt.jcrt_1719_21","volume":"19","author":"E Rani","year":"2023","unstructured":"Rani E, Nibhoria S, Nagpal N (2023) Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: a study in a tertiary care hospital. J Cancer Res Ther 19:1305\u20131310. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1719_21","journal-title":"J Cancer Res Ther"},{"key":"4563_CR114","doi-asserted-by":"publisher","unstructured":"Huellner MW, Mattei A, Ross S, Butea-Bocu M, Vosbeck J, Pauli C, Diebold J, Seifert B, Strobel K, Veit-Haibach P (2014) Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer. Clin Imaging 38:850\u20137. https:\/\/doi.org\/10.1016\/j.clinimag.2014.07.011","DOI":"10.1016\/j.clinimag.2014.07.011"},{"key":"4563_CR115","doi-asserted-by":"publisher","unstructured":"\u00c7elen \u0130, M\u00fcezzino\u011flu T, Ataman OY, Bak\u0131rdere S, Korkmaz M, Ne\u015fe N, \u015eenol F, Lekili M (2015) Selenium, nickel, and calcium levels in cancerous and non-cancerous prostate tissue samples and their relation with some parameters. Environ Sci Pollut Res Int 22:13070\u201313076. https:\/\/doi.org\/10.1007\/s11356-015-4555-y","DOI":"10.1007\/s11356-015-4555-y"},{"key":"4563_CR116","doi-asserted-by":"publisher","unstructured":"Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J (2010) Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Clin Chim Acta 411:172\u2013178. https:\/\/doi.org\/10.1016\/j.cca.2009.10.023","DOI":"10.1016\/j.cca.2009.10.023"},{"key":"4563_CR117","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/jnci\/91.19.1663","volume":"91","author":"DM Sutkowski","year":"1999","unstructured":"Sutkowski DM, Goode RL, Baniel J, Teater C, Cohen P, McNulty AM, Hsiung HM, Becker GW, Neubauer BL (1999) Growth regulation of prostatic stromal cells by prostate-specific antigen. J Natl Cancer Inst 91:1663\u20131669. https:\/\/doi.org\/10.1093\/jnci\/91.19.1663","journal-title":"J Natl Cancer Inst"},{"key":"4563_CR118","doi-asserted-by":"publisher","unstructured":"Li XM, Zhang L, Li J, Li Y, Wang HL, Ji GY, Kuwahara M, Zhao XJ (2005) Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng\/mL and 10 ng\/mL. Asian J Androl 7:323\u20138. https:\/\/doi.org\/10.1111\/j.1745-7262.2005.00044.x","DOI":"10.1111\/j.1745-7262.2005.00044.x"},{"key":"4563_CR119","doi-asserted-by":"publisher","unstructured":"Macke AJ, Petrosyan A (2022) Alcohol and prostate cancer: time to draw conclusions. Biomolecules 12. https:\/\/doi.org\/10.3390\/biom12030375","DOI":"10.3390\/biom12030375"},{"key":"4563_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41598-021-04116-8","volume":"12","author":"N Karunasinghe","year":"2022","unstructured":"Karunasinghe N, Minas TZ, Bao BY, Lee A, Wang A, Zhu S, Masters J, Goudie M, Huang SP, Jenkins FJ, Ferguson LR (2022) Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions. Sci Rep 12:55. https:\/\/doi.org\/10.1038\/s41598-021-04116-8","journal-title":"Sci Rep"},{"key":"4563_CR121","doi-asserted-by":"publisher","first-page":"Fso643","DOI":"10.2144\/fsoa-2020-0154","volume":"7","author":"G Tarantino","year":"2021","unstructured":"Tarantino G, Crocetto F, Vito CD, Martino R, Pandolfo SD, Creta M, Aveta A, Buonerba C, Imbimbo C (2021) Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study. Future Sci OA 7:Fso643. https:\/\/doi.org\/10.2144\/fsoa-2020-0154","journal-title":"Future Sci OA"},{"key":"4563_CR122","doi-asserted-by":"publisher","unstructured":"Wu CC, Pu YS, Wu HC, Yang CY, Chen YC (2011) Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium. Chemosphere 83:1188\u201391. https:\/\/doi.org\/10.1016\/j.chemosphere.2010.12.085","DOI":"10.1016\/j.chemosphere.2010.12.085"},{"key":"4563_CR123","doi-asserted-by":"publisher","unstructured":"Pizent A, Colak B, Kljakovi\u0107 Z, Telisman S (2009) Prostate-specific antigen (PSA) in serum in relation to blood lead concentration and alcohol consumption in men. Arh Hig Rada Toksikol 60:69\u201378. https:\/\/doi.org\/10.2478\/10004-1254-60-2009-1901","DOI":"10.2478\/10004-1254-60-2009-1901"},{"key":"4563_CR124","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00775-010-0675-5","volume":"15","author":"A Banas","year":"2010","unstructured":"Banas A, Kwiatek WM, Banas K, Gajda M, Pawlicki B, Cichocki T (2010) Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem 15:1147\u20131155. https:\/\/doi.org\/10.1007\/s00775-010-0675-5","journal-title":"J Biol Inorg Chem"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-025-04563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-025-04563-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-025-04563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:51:08Z","timestamp":1759913468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-025-04563-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":124,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4563"],"URL":"https:\/\/doi.org\/10.1007\/s12011-025-04563-8","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the used study protocols was provided by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (Trial No. 1142, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants received oral and written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}